Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Lin, Tseng Hsi ^a,b   Kuo, Hsing Chun ^a,c   Chou, Fen Pi ^a   Lu, Fung Jou ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACTIN; ARSENIC TRIOXIDE; BERBERINE; GELATINASE A; MATRIX METALLOPROTEINASE 14; MYC PROTEIN; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C EPSILON; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JUN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GELATINASE B; ISOENZYME; MMP2 PROTEIN, HUMAN; ORGANOARSENIC DERIVATIVE; OXIDE;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL MOTILITY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; GLIOMA; HUMAN; HUMAN CELL; INCUBATION TIME; METASTASIS INHIBITION; MIGRATION INHIBITION; MONOTHERAPY; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ZYMOGRAPHY; ANIMAL; CELL MOTION; CELL PROLIFERATION; DRUG EFFECT; GENE TRANSLOCATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

ACTINS; ANIMALS; ANTINEOPLASTIC AGENTS; ARSENICALS; BERBERINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; GLIOMA; HUMANS; ISOENZYMES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; OXIDES; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-EPSILON; RATS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 41549102101     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-58     Document Type: Article

References (61)

1. 3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins Proc Natl Acad Sci USA 2000, 97(10173):10178-27786. 10954752 10.1073/pnas.180290497
2. Wang ZY Arsenic compounds as anticancer agents Cancer Chemother Pharmacol 2001, 48(Suppl 1):S72-76. 10.1007/s002800100309 11587371
3. Bachleitner-Hofmann T Kees M Gisslinger H Arsenic trioxide: Acute promyelocytic leukemia and beyond Leuk Lymphoma 2002, 43:1535-1540. 10.1080/1042819021000002857 12400595
4. Miller WH Schipper HM Lee JS Singer J Waxman S Mechanisms of action of arsenic trioxide Cancer Res 2002, 62:3893-3903. 12124315
5. Berenson JR Yeh HS Arsenic compounds in the treatment of multiple myeloma: A new role for a historical remedy Clin Lymphoma Myeloma 2006, 7:192-198. 17229334
6. Li YM Broome JD Arsenic targets tubulins to induce apoptosis in myeloid leukemia cells Cancer Res 1999, 59:776-780. 10029061
7. Akao Y Yamada H Nakagawa Y Arsenic-induced apoptosis in malignant cells in vitro Leuk Lymphoma 2000, 37:53-63. 10721769
8. Murgo AJ Clinical trials of arsenic trioxide in hematologic and solid tumors: Overview of the National Cancer Institute Cooperative Research and Development Studies Oncologist 2001, 6 (Suppl 2):22-28. 10.1634/ theoncologist.6-suppl_2-22 11331437
9. Zhang TD Chen GQ Wang ZG Wang ZY Chen SJ Chen Z Arsenic trioxide, a therapeutic agent for APL Oncogene 2001, 20:7146-7153. 10.1038/ sj.onc.1204762 11704843
10. Bode AM Dong Z The paradox of arsenic: Molecular mechanisms of cell transformation and chemotherapeutic effects Crit Rev Oncol Hematol 2002, 42:5-24. 10.1016/S1040-8428(01)00215-3 11923065
11. Chen Z Chen GQ Shen ZX Sun GL Tong JH Wang ZY Chen SJ Expanding the use of arsenic trioxide: Leukemias and beyond Semin Hematol 2002, 39:22-26. 10.1053/shem.2002.33611 12012319
12. Halicka HD Smolewski P Darzynkiewicz Z Dai W Traganos F Arsenic trioxide arrests cells early in mitosis leading to apoptosis Cell Cycle 2002, 1:201-209. 12429934
13. Wei LH Lai KP Chen CA Cheng CH Huang YJ Chou CH Kuo ML Hsieh CY Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB Oncogene 2005, 24:390-398. 10.1038/sj.onc.1208192 15531921
14. Cheung WMW Chu PWK Kwong YL Effects of arsenic trioxide on the cellular proliferation, apopsosis and differentiation of human neuroblastoma cells Cancer Lett 2007, 246:122-128. 10.1016/j.canlet.2006.02.009 16569477
15. Ratnaike RN Acute and chronic arsenic toxicity Postgrad Med J 2003, 79:391-396. 10.1136/pmj.79.933.391 12897217
16. Couldwell WT Antel JP Yong VW Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C Neurosurgery 1992, 31:717-724. 10.1097/00006123-199210000-00015 1407458
17. da Rocha AB Mans DR Bernard EA Ruschel C Logullo AF Wetmore LA Leyva A Schwartsmann G Tamoxifen inhibits particulate-associated protein kinase C activity, and sensitises cultured human glioblastoma cells not to etoposide but to gamma-radiation and BCNU Eur J Cancer 1999, 35:833-839. 10.1016/S0959-8049(99)00003-9 10505046
18. Hofmann J Protein kinase C isozymes as potential targets for anticancer therapy Curr Cancer Drug Targets 2004, 4:125-146. 10.2174/ 1568009043481579 15032665
19. Mackay HJ Twelves CJ Protein kinase C: A target for anticancer drugs? Endocr Relat Cancer 2003, 10:389-396. 10.1677/erc.0.0100389 14503915
20. Cho K-K Mikkelsen T Lee YJ Jiang F Chopp M Rosenblum ML The role of protein kinase Cα in U-87 glioma invasion Int J Devl Neuroscience 1999. 17(5-6):447-461. 10.1016/S0736-5748(99)00054-4 10571407
21. Lahn MM Sundell KL Paterson BM The role of protein kinase C-α in malignancies of the nervous system and implications for the clinical development of the specific PKC-α inhibitor apprinocarsen Oncol Rep 2004, 11:515-522. 14719093
22. Zhang W Law RE Hinton DR Couldwell WT Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor Cancer Lett 1997, 120:31-38. 10.1016/ S0304-3835(97)00287-5 9570383
23. Masur K Lang K Niggemann B Zanker KS Entschladen F High PKC α and low E-cadherin expression contribute to high migration activity of colon carcinoma cells Mol Biol Cell 2001, 12:1973-1982. 55643 11451996
24. Serova M Ghoul A Benhadji KA Cvitkovic E Faivre S Calvo F Lokiec F Raymond E Preclinical and clinical development of novel agents that target the protein kinase C family Semin Oncol 2006, 33:466-478. 10.1053/ j.seminoncol.2006.04.009 16890801
25. Koivunen J Aaltonen V Koskela S Lehenkari P Laato M Peltonen J Protein kinase C α/β inhibitor Go6976 promotes formation of cell junctions and inhibits invation of urinary bladder carcinoma cells Cancer Res 2004, 64:5693-5701. 10.1158/0008-5472.CAN-03-3511 15313909
26. Roychowdhury D Lahn M Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): Potential role in breast cancer Semin Oncol 2003, 30:30-33. 12722024
27. Rao JS Molecular mechanisms of glioma invasiveness: The role of proteases Nat Rev Cancer 2003, 3:489-501. 10.1038/nrc1121 12835669
28. Sounni NE Noel A Membrane type-matrix metalloproteinases and tumor progression Biochimie 2005, 87:329-342. 10.1016/j.biochi.2004.07.012 15781320
29. Uhm JH Dooley NP Villemure J-G Yong VW Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C Clin Exp Metastasis 1996, 14:421-433. 10.1007/BF00128958 8871536
30. Park M-J Park I-C Hur J-H Rhee C-H Choe T-B Yi D-H Hong S-I Lee S-H Protein kinase C activation by phorbol ester increases in vitro invasion through regulation of matrix metalloproteinases/tissue inhibitors of metalloproteinases system in D54 human glioblastoma cells Neuroscience Lett 2000, 290(3):201-204. 10.1016/S0304-3940(00)01358-6 10963898
31. Schiller LR Review article: Anti-diarrhoeal pharmacology and therapeutics Aliment Pharmacol Ther 1995, 9:87-106. 7605866
32. Hwang JM Kuo HC Tseng TH Liu JY Chu CY Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells Arch Toxicol 2006, 80:62-73. 10.1007/s00204-005-0014-8 16189662
33. Anis KV Rajeshkumar NV Kuttan R Inhibition of chemical carcinogenesis by berberine in rats and mice J Pharmacy Pharmacol 2001, 53(5):763-768. 10.1211/0022357011775901 11370717
34. Kuo CL Chi CW Liu TY The anti-inflammatory potential of berberine in vitro and in vivo Cancer Lett 2004, 203:127-137. 10.1016/ j.canlet.2003.09.002 14732220
35. Yount G Qian Y Moore D Basila D West J Aldape K Arvold N Shalev N Haas-Kogan D Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro J Exp Therapeutics Oncol 2004, 4:137-143.
36. Peng PL Hsieh YS Wang CJ Hsu JL Chou FP Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2 Toxicol Appl Pharmacol 2006, 214:8-15. 10.1016/j.taap.2005.11.010 16387334
37. Letašiová S Jantová S Čipák L Mučková M Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells Cancer Lett 2006, 239:254-262. 10.1016/j.canlet.2005.08.024 16229943
38. Mantena SK Sharma SD Katiyar SK Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP Carcinogenesis 2006, 27:2018-2027. 10.1093/carcin/bgl043 16621886
39. Jing Y Dai J Chalmers-Redman RM Tatton WG Waxman S Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway Blood 1999, 94:2102-2111. 10477740
40. Benda P Lightbody J Sato G Levine L Sweet W Differentiated rat glial cell strain in culture Science 1968, 161:370-371. 10.1126/ science.161.3839.370 4873531
41. Mosmann T Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 1983, 65:55-63. 10.1016/0022-1759(83)90303-4 6606682
42. Kuo HC Kuo WH Lee YJ Lin WL Chou FP Tseng TH Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo Cancer Lett 2006, 234:199-208. 10.1016/j.canlet.2005.03.046 15885897
43. Kuo HC Lee HJ Hu CC Shun HI Tseng TH Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells Toxicol Appl Pharmacol 2006, 210:55-62. 10.1016/j.taap.2005.06.020 16051289
44. Pervaiz S Anti-cancer drugs of today and tomorrow: Are we close to making the turn from treating to curing cancer? Curr Pharm Des 2002, 8:1723-1734. 10.2174/1381612023394025 12171544
45. Larsson C Protein kinase C and the regulation of the actin cytoskeleton Cell Signal 2006, 18:276-284. 10.1016/j.cellsig.2005.07.010 16109477
46. Sharif TR Sharif M Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples Int J Oncol 1999, 15:237-243. 10402232
47. Assert R Kotter R Bisping G Scheppach W Stahlnecker E Muller KM Dusel G Schatz H Pfeiffer A Anti-proliferative activity of protein kinase C in apical compartments of human colonic crypts: Evidence for a less activated protein kinase C in small adenomas Int J Cancer 1999, 80:47-53. 10.1002/ (SICI)1097-0215(19990105)80:1<47::AID-IJC10<3.0.CO;2-J 9935229
48. da Rocha AB Mans DR Regner A Schwartsmann G Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas? Oncologist 2002, 7:17-33. 10.1634/theoncologist.7-1-17 11854544
49. Seger R Krebs EG The MAPK signaling cascade FASEB J 1995, 9:726-735. 7601337
50. Schonwasser DC Marais RM Marshall CJ Parker PJ Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes Mol Cell Biol 1998, 18:790-798. 108790 9447975
51. Auvinen M Cell transformation, invasion, and angiogenesis: A regulatory role for ornithine decarboxylase and polyamines? J Natl Cancer Inst 1997, 89:533-537. 10.1093/jnci/89.8.533 9106637
52. Lau CW Yao XQ Chen ZY Ko WH Huang Y Cardiovascular actions of berberine Cardiovasc Drug Rev 2001, 19:234-244. 11607041
53. Hwang JM Wang CJ Chou FP Tseng TH Hsieh YS Lin WL Chu CY Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage Arch Toxicol 2002, 76:664-670. 10.1007/s00204-002-0351-9 12415430
54. Bode AM Dong Z Apoptosis induction by arsenic: Mechanisms of action and possible clinical applications for treating therapy-resistant cancers Drug Resist Update 2000, 3 (1):21-29. 10.1054/drup.2000.0114 11498362
55. Cai X Shen YL Zhu Q Jia PM Yu Y Zhou L Huang Y Zhang JW Xiong SM Chen SJ Wang ZY Chen Z Chen GQ Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia Leukemia 2000, 14:262-270. 10.1038/ sj.leu.2401650 10673743
56. Levicar N Nuttall RK Lah TT Proteases in brain tumour progression Acta Neurochir (Wien) 2003, 145:825-838. 10.1007/s00701-003-0097-z 14505115
57. Bredel M Pollack IF The role of protein kinase C (PKC) in the evolution and proliferation of malignant gliomas, and the application of PKC inhibition as a novel approach to anti-glioma therapy Acta Neurochir (Wien) 1997, 139:1000-1013. 10.1007/BF01411552 9442212
58. Mandil R Ashkenazi E Blass M Kronfeld I Kazimirsky G Rosenthal G Umansky F Lorenzo PS Blumberg PM Brodie C Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells Cancer Res 2001, 61:4612- 4619. 11389098
59. Dong Z The molecular mechanisms of arsenic-induced cell transformation and apoptosis Environ Health Perspect 2002, 110:757-759. 1241240 12426127
60. Chen NY Ma WY Huang C Ding M Dong Z Activation of PKC is required for arsenite-induced signal transduction J Environ Pathol Toxicol Oncol 2000, 19:297-305. 10983896
61. Au WY Tam S Fong BM Kwong YL Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia Blood 2006, 107:3012-3013. 10.1182/ blood-2005-10-4175 16554490